Literature DB >> 32821756

The Construction of Carbon Nanotubes Containing an Anti-Bacterial Chemical Component and its Effect on MDR and XDR Isolates of Pseudomonas Aeruginosa.

Kamelia Banihashemi1, Behnam Sobouti2, Iraj Mehregan1, Ronak Bakhtiari3, Nour Amirmozafari4.   

Abstract

BACKGROUND: Pseudomonas aeruginosa is an opportunistic human pathogen that causes severe acute and chronic nosocomial infections, especially in immunocompromised burn patients. and can lead to severe mortality and morbidity. The emergence of antibiotic resistant P. aeruginosa infections has created significant challenges in treating these patients. A potential alternative treatment for antibiotic resistant pathogens includes the use of carbon nanotubes (CNTs), which have received considerable attention due to their potent antibacterial activity. The aim of this study was to construct a novel CNT containing an anti-bacterial chemical component to effectively combat drug resistant P. aeruginosa infections.
METHODS: In this study, a novel chemical component was synthesized and coated the CNT. The antimicrobial effects were then evaluated on MDR, XDR, and PDR strains of P. aeruginosa isolated from burn patients. Antibiotic susceptibility was evaluated using the disk diffusion test and minimum inhibitory concentration (MIC) testing. In order to determine the potential cytotoxicity, an MTT assay was performed on Human Dermal Fibroblasts. The effect of treatment on the expression of wound healing genes was analyzed via qRT-PCR.
RESULTS: Experimental data indicates that our CNT coated chemical compound had antibacterial properties, negligible cytotoxicity, and could accelerate the wound healing process.
CONCLUSION: Given the antibacterial properties of our CNT chemical compound, it has the potential to treat and reduce the occurrence of multi-drug resistant P. aeruginosa burn wound infections and aid in wound healing by turning on genes (VEGFA, EGF and PDEGF) involved in the wound healing process.

Entities:  

Keywords:  Anti-Bacterial drugs; Drug resistance; MDR; Nanotubes Carbon; Pseudomonas aeruginosa; XDR

Year:  2020        PMID: 32821756      PMCID: PMC7424415          DOI: 10.29252/rbmb.9.1.89

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  18 in total

Review 1.  Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.

Authors:  Yvonne Pfeifer; Angela Cullik; Wolfgang Witte
Journal:  Int J Med Microbiol       Date:  2010-05-27       Impact factor: 3.473

2.  Cell sensitivity assays: the MTT assay.

Authors:  Johan van Meerloo; Gertjan J L Kaspers; Jacqueline Cloos
Journal:  Methods Mol Biol       Date:  2011

3.  Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.

Authors:  Helio S Sader; Mariana Castanheira; Rodrigo E Mendes; Robert K Flamm; David J Farrell; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

Review 4.  Mechanisms of action and resistance of older and newer fluoroquinolones.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

5.  Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. The Greek Pseudomonas Aeruginosa Study Group.

Authors:  P T Tassios; V Gennimata; A N Maniatis; C Fock; N J Legakis
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

6.  A study of organisms causing surgical site infections and their antimicrobial susceptibility in a tertiary care government hospital.

Authors:  Aniruddha S Mundhada; Sunita Tenpe
Journal:  Indian J Pathol Microbiol       Date:  2015 Apr-Jun       Impact factor: 0.740

7.  Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.

Authors:  José-Manuel Rodríguez-Martínez; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

8.  Bacterial and antimicrobial susceptibility profile and the prevalence of sepsis among burn patients at the burn unit of Cipto Mangunkusumo Hospital.

Authors:  A Wardhana; R Djan; Z Halim
Journal:  Ann Burns Fire Disasters       Date:  2017-06-30

9.  Antibiotic susceptibility patterns of Pseudomonas aeruginosa at a tertiary care hospital in Gujarat, India.

Authors:  Viren A Javiya; Somsuvra B Ghatak; Kamlesh R Patel; Jagruti A Patel
Journal:  Indian J Pharmacol       Date:  2008-10       Impact factor: 1.200

10.  Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections.

Authors:  Nattawan Palavutitotai; Anupop Jitmuang; Sasima Tongsai; Pattarachai Kiratisin; Nasikarn Angkasekwinai
Journal:  PLoS One       Date:  2018-02-22       Impact factor: 3.240

View more
  2 in total

1.  Molecular Investigation of Outer Membrane Channel Genes Among Multidrug Resistance Clinical Pseudomonas Aeruginosa Isolates.

Authors:  Maytham Hassan Jasim Al-Thabhawee; Hussein Muttaleb Al-Dahmoshi
Journal:  Rep Biochem Mol Biol       Date:  2022-04

2.  Antibacterial effect of carbon nanotube containing chemical compounds on drug-resistant isolates of Acinetobacter baumannii.

Authors:  Kamelia Banihashemi; Nour Amirmozafari; Iraj Mehregan; Ronak Bakhtiari; Behnam Sobouti
Journal:  Iran J Microbiol       Date:  2021-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.